Financial Year |
March 31 2023 |
Monetary Funds |
4,290,684,290.31 |
Held-for-trading Financial Assets |
-- |
Notes Receivable |
439,348,677.72 |
Accounts Receivable |
16,983,750,445.20 |
Advances to Suppliers |
397,116,450.84 |
Other Receivables |
4,770,430,219.64 |
Amounts Due From Related Companies |
-- |
Interest Receivable |
601,292.40 |
Dividend Receivable |
1,478,743.04 |
Inventories |
9,506,788,294.21 |
Among: Consumptive Biological Assets |
-- |
Non-Current Assets Maturing Within One Year |
-- |
Other Current Assets |
304,383,945.58 |
Total Current Assets |
63,890,807,114.55 |
Available-for-Sale Financial Asset |
-- |
Held-to-maturity Investments |
-- |
Long-Term Account Receivable |
793,524,759.94 |
Long-term Equity Investment |
770,424,511.26 |
Investment Properties |
2,918,845,395.50 |
Fixed Assetes |
1,458,067,989.92 |
Under-construction Projects |
336,316,132.99 |
Construction Materials |
-- |
Disposal of Fixed Assets |
-- |
Capitalized Biological Assets |
616,374.90 |
Oil and Gas Assets |
-- |
Intangible Assets |
6,688,071,325.13 |
R&D expenses |
57,799,301.96 |
Goodwill |
-- |
Long-Term Deferred and Prepaid Expenses |
32,972,482.96 |
Deferred Income Tax Assets |
555,344,252.20 |
Other Non-Current Assets |
2,057,511,701.66 |
Sub-Total of Non-Current Assets |
16,834,334,496.92 |
Total Assets |
80,725,141,611.47 |
Short-Term Loans |
10,166,150,718.35 |
Trading Financial liabilities |
-- |
Notes Payable |
1,798,498,725.19 |
Accounts Payable |
32,685,145,588.58 |
Accounts Received In Advance |
141,522.20 |
Employee Compensation Payable |
74,892,894.09 |
Taxes Payable |
482,561,060.62 |
Interest Payable |
-- |
Dividend Payable |
4,143,969.46 |
Other payables |
10,748,160,127.04 |
Due to Related Companies |
-- |
Non-Current Liabilities Due Within One Year |
2,247,101,163.24 |
Other Current Liabilities |
2,863,507,557.96 |
Sub-Total of Current Liabilities |
65,142,948,880.33 |
Long-term Loans |
4,200,358,382.06 |
Bonds Payable |
1,331,524,406.68 |
Long-Term Accounts Payable |
647,508,349.74 |
Special Payable |
-- |
Estimatied Liabilities |
29,340,055.44 |
Deferred Income Tax Liabilities |
178,958,234.82 |
Other Non-Current Liabilities |
-- |
Sub-Total of Non-Current Liabilities |
6,576,474,055.84 |
Total Liabilities |
71,719,422,936.17 |
Paid-In Capital(Or Share Stock) |
1,901,788,174.00 |
Capital Surplus |
1,646,986,022.03 |
Surplus Reserve |
331,761,359.12 |
LESS:Treasury Stock |
-- |
Undistributed Profits |
2,147,114,720.91 |
Minority Stockholder's Interest |
323,535,074.76 |
Foreign Currency Capital |
-- |
Abnormal Management Project Income Adjusted |
-- |
Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
8,682,183,600.54 |
Owner's Equity(Stockholder's Equity) |
9,005,718,675.30 |
Total Liabilities and Owner's Equity(Stockholder's Equity) |
80,725,141,611.47 |